Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × prexasertib × 30 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Endometrial Neoplasms 1

Interventions

Specimen Handling 402 Magnetic Resonance Spectroscopy 330 pembrolizumab 298 Biopsy 227 Carboplatin 226 Cisplatin 189 Cyclophosphamide 172 Nivolumab 167 Gemcitabine 166 Paclitaxel 153 Bevacizumab 120 Radiotherapy 113 atezolizumab 98 Dexamethasone 98 Docetaxel 96 venetoclax 93 fludarabine 92 Oxaliplatin 88 Rituximab 87 durvalumab 84 Fluorouracil 81 Radiation 80 Pemetrexed 80 Doxorubicin 80 Prednisone 75 Ipilimumab 74 Taxes 72 X-Rays 67 Lenalidomide 67 Capecitabine 67

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05548296 2026-03-24

A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma

Acrivon Therapeutics

Phase 2 Recruiting

Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡